These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1186467)

  • 41. Total exchangeable and red cell potassium in patients with chronic renal failure.
    Loureiro AA; Ferreira MN; Ianhez LE; Libermann B; Waschenberg BL; Sabbaga E
    Arq Bras Cardiol; 1975 Oct; 28(5):517-22. PubMed ID: 1217999
    [No Abstract]   [Full Text] [Related]  

  • 42. [Intra- and extracellular electrolyte and pH measurements before and after hemodialysis].
    Zumkley H; Schürmeyer E
    Z Klin Chem Klin Biochem; 1968 Jun; 6(4):350-2. PubMed ID: 5728063
    [No Abstract]   [Full Text] [Related]  

  • 43. [The ECG changes during the performance of hemodialysis using dialysis solution concentrates with different potassium levels in patients with chronic kidney failure and normokalemia].
    Alavi AA; Riabykina GV; Zaruba AIu; Kutsenko AI; Kukharchuk VV; Eliseev AO
    Ter Arkh; 1993; 65(4):58-60. PubMed ID: 8059409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute decrease in plasma potassium concentration following intravenous mannitol as a result of hemodilution in stable chronic hemodialysis patients.
    Swan AM; DeVita MV; Michelis MF
    Clin Nephrol; 1997 Apr; 47(4):276-7. PubMed ID: 9128799
    [No Abstract]   [Full Text] [Related]  

  • 45. The contribution of nutrition to the protective value of high plasma aldosterone concentrations in hemodialysis patients.
    Diskin CJ
    Hypertens Res; 2007 Aug; 30(8):751-2; author reply 752-4. PubMed ID: 17917323
    [No Abstract]   [Full Text] [Related]  

  • 46. [Changes in the alkaline-acid status and some plasma electrolytes in chronic hemodialysis patients].
    Nenov D; Chankova P; Dimitrov KH
    Vutr Boles; 1975; 14(4):37-9. PubMed ID: 1224593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pathogenetic participation of exchangeable sodium and plasma renin activity in the genesis and development of hypertension in patients with chronic renal insufficiency on maintenance dialysis].
    Horký K; Kapitola J; Lachmanová J; Straková M; Tomásek R; Kaslíková J
    Cas Lek Cesk; 1974 Jun; 113(24):732-40. PubMed ID: 4451960
    [No Abstract]   [Full Text] [Related]  

  • 48. [Correction of acid-base imbalance in patients with chronic renal failure during hemodialysis].
    Khodas MIa; Piatnitskaia GKh; Levitskiĭ ER; Sagalovich GM; Petrosova MA
    Klin Med (Mosk); 1974 Mar; 52(3):47-53. PubMed ID: 4466949
    [No Abstract]   [Full Text] [Related]  

  • 49. [Sodium, potassium, calcium in chronic renal insufficiency].
    Locatelli F; Ponti R; Di Filippo S
    G Ital Cardiol; 1990 May; 20(5):449-62. PubMed ID: 2210169
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of tap water on the level of plasma magnesium in patients with terminal stage of chronic renal insufficiency treated by hemodialysis].
    Bazhanova IM; Levitskiĭ ER
    Urol Nefrol (Mosk); 1975; (1):35-8. PubMed ID: 1118971
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of hemodialysis on the metabolic clearance rate, plasma concentration and blood production rate of aldosterone in anephric man.
    Read VH; McCaa CS; Bower JD; McCaa RE
    J Clin Endocrinol Metab; 1973 Apr; 36(4):773-8. PubMed ID: 4686385
    [No Abstract]   [Full Text] [Related]  

  • 52. Glucose-induced paradoxical increase in HGH with potentiated decrease in serum potassium in chronic renal failure.
    Rado JP
    Horm Metab Res; 1982 Feb; 14(2):105. PubMed ID: 7040190
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical efficacy and pharmacokinetics of clonidine in hemodialysis and renal insufficiency.
    Hulter HN; Licht JH; Ilnicki LP; Singh S
    J Lab Clin Med; 1979 Aug; 94(2):223-31. PubMed ID: 458242
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of hemodialysis on plasma aldosterone in anephric patients (author's transl)].
    Vetter W; Záruba K; Armbruster H; Beckerhoff R; Siegenthaler W
    Klin Wochenschr; 1975 Jan; 53(1):17-20. PubMed ID: 1123892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of plasma aldosterone in anephric and non-nephrectomized patients during hemodialysis treatment.
    Olgaard K; Madsen S
    Acta Med Scand; 1977; 201(5):457-62. PubMed ID: 899867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased secretion of potassium in the rectum of humans with chronic renal failure.
    Martin RS; Panese S; Virginillo M; Gimenez M; Litardo M; Arrizurieta E; Hayslett JP
    Am J Kidney Dis; 1986 Aug; 8(2):105-10. PubMed ID: 3740056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of hemodialysis on plasma aldosterone concentration in nephrectomized patients.
    McCaa RE; McCaa CS; Read VH; Bower JD
    Trans Am Soc Artif Intern Organs; 1972; 18(0):239-43, 248. PubMed ID: 4679877
    [No Abstract]   [Full Text] [Related]  

  • 58. Aldosterone and Insulin Resistance: Vicious Combination in Patients on Maintenance Hemodialysis.
    Wakino S; Minakuchi H; Miya K; Takamatsu N; Tada H; Tani E; Inamoto H; Minakuchi J; Kawashima S; Itoh H
    Ther Apher Dial; 2018 Apr; 22(2):142-151. PubMed ID: 29271574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diltiazem enhances potassium disposal in subjects with end-stage renal disease.
    Solomon R; Dubey A
    Am J Kidney Dis; 1992 May; 19(5):420-6. PubMed ID: 1585928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma zinc in relation to creatinine, electrolytes, and albumin in renal failure.
    Kumar S; Mangal BD; Srivastava DK; Agarwal K; Seth ON
    Indian J Med Res; 1982 Mar; 75():417-21. PubMed ID: 7106878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.